Cerebral palsy: The whys and hows

Archives of Disease in Childhood: Education and Practice Edition

Volumn 97, Issue 4, 2012, Pages 122-131

  Fairhurst, Charlie ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BOTULINUM TOXIN A; CARBIDOPA PLUS LEVODOPA; DANTROLENE; DIAZEPAM; TETRABENAZINE; TIZANIDINE; TRIHEXYPHENIDYL;

ACUPUNCTURE; AGITATION; ALEXANDER TECHNIQUE; AROMATHERAPY; BRAIN DEPTH STIMULATION; BRAIN DEVELOPMENT; CEREBRAL PALSY; CHINESE MEDICINE; CHIROPRACTIC; CHOREA; CONSTIPATION; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DISORIENTATION; DORSAL RHIZOTOMY; DRUG DOSE INCREASE; DRUG MEGADOSE; DYSTONIA; GASTROINTESTINAL SYMPTOM; GLIA CELL; GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM; HIPPOTHERAPY; HOMEOPATHY; HUMAN; HYPERBARIC OXYGEN; HYPOTENSION; INSOMNIA; LIVER FAILURE; LOW DRUG DOSE; MOOD DISORDER; MOTOR CONTROL; MUSCLE HYPERTONIA; MUSCLE HYPOTONIA; NAUSEA; ORTHOPEDIC SURGERY; ORTHOTICS; OSTEOPATHIC MEDICINE; PATHOPHYSIOLOGY; PILATES; PRIORITY JOURNAL; REFLEXOLOGY; REVIEW; SCIENCE; SEDATION; SEIZURE; SIDE EFFECT; SPASTICITY; URINE RETENTION; WEAKNESS; XEROSTOMIA; YOGA;

BOTULINUM TOXINS, TYPE A; BRAIN; CEREBRAL PALSY; CHILD; COMPLEMENTARY THERAPIES; DEEP BRAIN STIMULATION; DISABILITY EVALUATION; DOPAMINE AGENTS; DYSTONIC DISORDERS; HUMANS; INFUSION PUMPS; INJECTIONS, INTRAMUSCULAR; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; ORTHOPEDIC PROCEDURES; PATIENT CARE TEAM; PLURIPOTENT STEM CELLS; RHIZOTOMY; SEVERITY OF ILLNESS INDEX;

EID: 84864872961     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/edpract-2011-300593     Document Type: Review

References (32)

1. Surveillance of Cerebral Palsy in Europe (SCPE). Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Dev Med Child Neurol 2000;42:816-24.
2. Bax M, Goldstein M, Rosenbaum P, et al. Proposed definition and classification of cerebral palsy, April 2005. Dev Med Child Neurol 2005;47:571-6. (Pubitemid 41131619)
3. Eyre JA. Corticospinal tract development and its plasticity after perinatal injury. Neurosci Biobehav Rev 2007;31:1136-49. (Pubitemid 350160952)
4. Sawyer MG, Bittman M, LA Greca AM, et al. Time demands of caring for children with cerebral palsy: what are the implications for maternal mental health? Dev Med Child Neurol 2011;53:338-43.
5. Palisano R, Rosenbaum P, Walter S, et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997;39:214-23. (Pubitemid 27226331)
6. Eliasson AC, Krumlinde-Sundholm L, Rösblad B, et al. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol 2006;48:549-54.
7. Johnston MV. Plasticity in the developing brain: implications for rehabilitation. Dev Disabil Res Rev 2009;15:94-101.
8. Korzeniewski SJ, Birbeck G, DeLano MC, et al. A systematic review of neuroimaging for cerebral palsy. J Child Neurol 2008;23:216-27.
9. Leonard JM, Cozens AL, Reid SM, et al. Should children with cerebral palsy and normal imaging undergo testing for inherited metabolic disorders? Dev Med Child Neurol 2011;53:226-32.
10. Damiano DL. Rehabilitative therapies in cerebral palsy: the good, the not as good, and the possible. J Child Neurol 2009;24:1200-4.
11. Anttila H, Suoranta J, Malmivaara A, et al. Effectiveness of physiotherapy and conductive education interventions in children with cerebral palsy: a focused review. Am J Phys Med Rehabil 2008;87:478-501.
12. Delgado MR, Hirtz D, Aisen M, et al. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2010;74:336-43.
13. Cloud LJ, Jinnah HA. Treatment strategies for dystonia. Expert Opin Pharmacother 2010;11:5-15.
14. Carranza-del Rio J, Clegg NJ, Moore A, et al. Use of trihexyphenidyl in children with cerebral palsy. Pediatr Neurol 2011;44:202-6.
15. Mariotti P, Fasano A, Contarino MF, et al. Management of status dystonicus: our experience and review of the literature. Mov Disord 2007;22:963-8. (Pubitemid 46999292)
16. Simpson DM, Gracies JM, Graham HK, et al. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;70:1691-8. (Pubitemid 351644137)
17. Heinen F, Desloovere K, Schroeder AS, et al. The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 2010;14:45-66.
18. Gough M, Fairhurst C, Shortland AP. Botulinum toxin and cerebral palsy: time for reflection? Dev Med Child Neurol 2005;47:709-12. (Pubitemid 41447783)
19. Katchburian L, Cawker S, Coombe et al. Evidence based guidance for physiotherapists 2008. Association of Paediatric Chartered Physiotherapists 2008.
20. Dan B, Motta F, Vles JS, et al. Consensus on the appropriate use of intrathecal baclofen (ITB) therapy in paediatric spasticity. Eur J Paediatr Neurol 2010;14:19-28.
21. National Institute for Health and Clinical Excellence Interventional Procedures Programme. Interventional Procedure Overview of Selective Dorsal Rhizotomy for Spasticity in Cerebral Palsy, 2009. IP 318-2.
22. Grunt S, Becher JG, Vermeulen RJ. Long-term outcome and adverse effects of selective dorsal rhizotomy in children with cerebral palsy: a systematic review. Dev Med Child Neurol 2011;53:490-8.
23. Kan P, Gooch J, Amini A, et al. Surgical treatment of spasticity in children: comparison of selective dorsal rhizotomy and intrathecal baclofen pump implantation. Childs Nerv Syst 2008;24:239-43.
24. Buckon CE, Thomas SS, Piatt JH Jr, et al. Selective dorsal rhizotomy versus orthopedic surgery: a multidimensional assessment of outcome efficacy. Arch Phys Med Rehabil 2004;85:457-65. (Pubitemid 38879375)
25. Wong AM, Pei YC, Lui TN, et al. Comparison between botulinum toxin type A injection and selective posterior rhizotomy in improving gait performance in children with cerebral palsy. J Neurosurg 2005;102:385-9. (Pubitemid 44968474)
26. Vidailhet M, Yelnik J, Lagrange C, et al. Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study. Lancet Neurol 2009;8:709-17.
27. Hägglund G, Andersson S, Düppe H, et al. Prevention of dislocation of the hip in children with cerebral palsy. The first ten years of a population-based prevention programme. J Bone Joint Surg Br 2005;87:95-101.
28. Robb JE, Brunner R. Orthopaedic Management Of Cerebral Palsy, In Children's Orthopaedics And Fractures. London, UK: Springer Verlag, London Ltd 2010:307-25.
29. Regenberg AC, Hutchinson LA, Schanker B, et al. Medicine on the fringe: stem cell-based interventions in advance of evidence. Stem Cells 2009;27:2312-19.
30. Liptak GS. Complementary and alternative therapies for cerebral palsy. Ment Retard Dev Disabil Res Rev 2005;11:156-63. (Pubitemid 40981697)
31. Wyatt K, Edwards V, Franck L, et al. Cranial osteopathy for children with cerebral palsy: a randomised controlled trial. Arch Dis Child 2011;96:505-12.
32. Mackeith Press. The adult with cerebral palsy. Dev Med Child Neurol 2009;51(suppl 4):1-184.